nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR2—osteoporosis	0.813	1	CbGaD
Nabilone—Dronabinol—CNR2—osteoporosis	0.00616	1	CrCbGaD
Nabilone—CNR1—N-cadherin signaling events—GSN—osteoporosis	0.00442	0.108	CbGpPWpGaD
Nabilone—CNR1—Small Ligand GPCRs—CNR2—osteoporosis	0.00423	0.103	CbGpPWpGaD
Nabilone—CNR1—N-cadherin signaling events—LRP5—osteoporosis	0.00384	0.0936	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CALCR—osteoporosis	0.000853	0.0208	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—PTH1R—osteoporosis	0.000853	0.0208	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—RAP1A—osteoporosis	0.000844	0.0206	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—ALPL—osteoporosis	0.000811	0.0197	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—BMP2—osteoporosis	0.000712	0.0173	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CALCR—osteoporosis	0.000669	0.0163	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTH1R—osteoporosis	0.000669	0.0163	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CNR2—osteoporosis	0.000566	0.0138	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000525	0.0128	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CALCR—osteoporosis	0.000482	0.0117	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTH1R—osteoporosis	0.000482	0.0117	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00045	0.011	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—PTH—osteoporosis	0.000448	0.0109	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CALCR—osteoporosis	0.000438	0.0107	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTH1R—osteoporosis	0.000438	0.0107	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—SPP1—osteoporosis	0.000431	0.0105	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—WNT1—osteoporosis	0.00041	0.00999	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS2—osteoporosis	0.00039	0.00949	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—ADCY5—osteoporosis	0.000384	0.00935	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—MGLL—osteoporosis	0.000383	0.00932	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTH1R—osteoporosis	0.000378	0.00921	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CALCR—osteoporosis	0.000378	0.00921	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—PTHLH—osteoporosis	0.000371	0.00904	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTH—osteoporosis	0.000352	0.00856	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MGLL—osteoporosis	0.000348	0.00846	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTH1R—osteoporosis	0.000343	0.00836	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CALCR—osteoporosis	0.000343	0.00836	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CNR2—osteoporosis	0.000343	0.00834	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS1—osteoporosis	0.000341	0.00829	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CALCA—osteoporosis	0.000327	0.00796	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—WNT1—osteoporosis	0.000322	0.00784	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—ADCY5—osteoporosis	0.000301	0.00733	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—MGLL—osteoporosis	0.0003	0.00731	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTHLH—osteoporosis	0.000291	0.00709	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SOST—osteoporosis	0.000286	0.00696	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—POMC—osteoporosis	0.000282	0.00687	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MGLL—osteoporosis	0.000273	0.00664	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTH1R—osteoporosis	0.000259	0.00629	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CALCR—osteoporosis	0.000259	0.00629	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CALCA—osteoporosis	0.000256	0.00624	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTH—osteoporosis	0.000253	0.00616	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTH—osteoporosis	0.00023	0.0056	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000225	0.00547	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SOST—osteoporosis	0.000224	0.00546	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—POMC—osteoporosis	0.000222	0.00539	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—WNT1—osteoporosis	0.000211	0.00513	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTHLH—osteoporosis	0.00021	0.00511	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MGLL—osteoporosis	0.000205	0.005	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTH1R—osteoporosis	0.000203	0.00494	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CALCR—osteoporosis	0.000203	0.00494	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LRP5—osteoporosis	0.0002	0.00488	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTH—osteoporosis	0.000199	0.00484	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CNR2—osteoporosis	0.000194	0.00471	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LRP6—osteoporosis	0.000192	0.00467	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTHLH—osteoporosis	0.000191	0.00464	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CALCA—osteoporosis	0.000185	0.0045	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTH—osteoporosis	0.00018	0.00439	CbGpPWpGaD
Nabilone—Loss of consciousness—Zoledronate—osteoporosis	0.000177	0.00127	CcSEcCtD
Nabilone—Pharyngitis—Estradiol—osteoporosis	0.000177	0.00127	CcSEcCtD
Nabilone—Hypersensitivity—Estropipate—osteoporosis	0.000176	0.00126	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000176	0.00429	CbGpPWpGaD
Nabilone—Vomiting—Etidronic acid—osteoporosis	0.000176	0.00126	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CNR2—osteoporosis	0.000176	0.00428	CbGpPWpGaD
Nabilone—Cough—Zoledronate—osteoporosis	0.000176	0.00126	CcSEcCtD
Nabilone—Tachycardia—Pamidronate—osteoporosis	0.000176	0.00126	CcSEcCtD
Nabilone—Rash—Etidronic acid—osteoporosis	0.000175	0.00125	CcSEcCtD
Nabilone—Convulsion—Zoledronate—osteoporosis	0.000174	0.00125	CcSEcCtD
Nabilone—Dermatitis—Etidronic acid—osteoporosis	0.000174	0.00125	CcSEcCtD
Nabilone—Vertigo—Conjugated Estrogens—osteoporosis	0.000174	0.00125	CcSEcCtD
Nabilone—Hyperhidrosis—Pamidronate—osteoporosis	0.000174	0.00124	CcSEcCtD
Nabilone—Syncope—Conjugated Estrogens—osteoporosis	0.000174	0.00124	CcSEcCtD
Nabilone—Hypertension—Zoledronate—osteoporosis	0.000174	0.00124	CcSEcCtD
Nabilone—Hypersensitivity—Alendronate—osteoporosis	0.000174	0.00124	CcSEcCtD
Nabilone—Headache—Etidronic acid—osteoporosis	0.000173	0.00124	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000172	0.00123	CcSEcCtD
Nabilone—Asthenia—Estropipate—osteoporosis	0.000172	0.00123	CcSEcCtD
Nabilone—Visual impairment—Estradiol—osteoporosis	0.000172	0.00123	CcSEcCtD
Nabilone—Anorexia—Pamidronate—osteoporosis	0.000172	0.00123	CcSEcCtD
Nabilone—Myalgia—Zoledronate—osteoporosis	0.000171	0.00123	CcSEcCtD
Nabilone—Chest pain—Zoledronate—osteoporosis	0.000171	0.00123	CcSEcCtD
Nabilone—Arthralgia—Zoledronate—osteoporosis	0.000171	0.00123	CcSEcCtD
Nabilone—Palpitations—Conjugated Estrogens—osteoporosis	0.000171	0.00123	CcSEcCtD
Nabilone—Insomnia—Risedronate—osteoporosis	0.000171	0.00122	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—POMC—osteoporosis	0.000171	0.00416	CbGpPWpGaD
Nabilone—Anxiety—Zoledronate—osteoporosis	0.000171	0.00122	CcSEcCtD
Nabilone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00017	0.00122	CcSEcCtD
Nabilone—Paraesthesia—Risedronate—osteoporosis	0.00017	0.00122	CcSEcCtD
Nabilone—Pruritus—Estropipate—osteoporosis	0.000169	0.00121	CcSEcCtD
Nabilone—Discomfort—Zoledronate—osteoporosis	0.000169	0.00121	CcSEcCtD
Nabilone—Asthenia—Alendronate—osteoporosis	0.000169	0.00121	CcSEcCtD
Nabilone—Hypersensitivity—Ibandronate—osteoporosis	0.000169	0.00121	CcSEcCtD
Nabilone—Cough—Conjugated Estrogens—osteoporosis	0.000169	0.00121	CcSEcCtD
Nabilone—Dyspnoea—Risedronate—osteoporosis	0.000169	0.00121	CcSEcCtD
Nabilone—Hypotension—Pamidronate—osteoporosis	0.000168	0.0012	CcSEcCtD
Nabilone—Convulsion—Conjugated Estrogens—osteoporosis	0.000168	0.0012	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CALCA—osteoporosis	0.000168	0.00408	CbGpPWpGaD
Nabilone—Dry mouth—Zoledronate—osteoporosis	0.000168	0.0012	CcSEcCtD
Nabilone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000167	0.0012	CcSEcCtD
Nabilone—Pruritus—Alendronate—osteoporosis	0.000167	0.00119	CcSEcCtD
Nabilone—Dyspepsia—Risedronate—osteoporosis	0.000167	0.00119	CcSEcCtD
Nabilone—Eye disorder—Estradiol—osteoporosis	0.000167	0.00119	CcSEcCtD
Nabilone—Tinnitus—Estradiol—osteoporosis	0.000166	0.00119	CcSEcCtD
Nabilone—Constipation—Ethinyl Estradiol—osteoporosis	0.000166	0.00119	CcSEcCtD
Nabilone—Confusional state—Zoledronate—osteoporosis	0.000166	0.00119	CcSEcCtD
Nabilone—Hypersensitivity—Calcitriol—osteoporosis	0.000166	0.00119	CcSEcCtD
Nabilone—Flushing—Estradiol—osteoporosis	0.000165	0.00118	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—WNT1—osteoporosis	0.000165	0.00402	CbGpPWpGaD
Nabilone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000165	0.00118	CcSEcCtD
Nabilone—Chest pain—Conjugated Estrogens—osteoporosis	0.000165	0.00118	CcSEcCtD
Nabilone—Myalgia—Conjugated Estrogens—osteoporosis	0.000165	0.00118	CcSEcCtD
Nabilone—Asthenia—Ibandronate—osteoporosis	0.000165	0.00118	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000165	0.00401	CbGpPWpGaD
Nabilone—Anxiety—Conjugated Estrogens—osteoporosis	0.000165	0.00118	CcSEcCtD
Nabilone—Nausea—Etidronic acid—osteoporosis	0.000164	0.00118	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000164	0.00117	CcSEcCtD
Nabilone—Diarrhoea—Estropipate—osteoporosis	0.000164	0.00117	CcSEcCtD
Nabilone—Infection—Zoledronate—osteoporosis	0.000163	0.00117	CcSEcCtD
Nabilone—Fatigue—Risedronate—osteoporosis	0.000163	0.00117	CcSEcCtD
Nabilone—Insomnia—Pamidronate—osteoporosis	0.000163	0.00116	CcSEcCtD
Nabilone—Pruritus—Ibandronate—osteoporosis	0.000162	0.00116	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TLN1—osteoporosis	0.000162	0.00394	CbGpPWpGaD
Nabilone—Constipation—Risedronate—osteoporosis	0.000162	0.00116	CcSEcCtD
Nabilone—Pain—Risedronate—osteoporosis	0.000162	0.00116	CcSEcCtD
Nabilone—Shock—Zoledronate—osteoporosis	0.000162	0.00116	CcSEcCtD
Nabilone—Paraesthesia—Pamidronate—osteoporosis	0.000162	0.00116	CcSEcCtD
Nabilone—Diarrhoea—Alendronate—osteoporosis	0.000161	0.00115	CcSEcCtD
Nabilone—Asthenia—Calcitriol—osteoporosis	0.000161	0.00115	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MGLL—osteoporosis	0.000161	0.00392	CbGpPWpGaD
Nabilone—Dyspnoea—Pamidronate—osteoporosis	0.00016	0.00115	CcSEcCtD
Nabilone—Tachycardia—Zoledronate—osteoporosis	0.00016	0.00115	CcSEcCtD
Nabilone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00016	0.00114	CcSEcCtD
Nabilone—Chills—Estradiol—osteoporosis	0.00016	0.00114	CcSEcCtD
Nabilone—Somnolence—Pamidronate—osteoporosis	0.00016	0.00114	CcSEcCtD
Nabilone—Pruritus—Calcitriol—osteoporosis	0.000159	0.00114	CcSEcCtD
Nabilone—Hyperhidrosis—Zoledronate—osteoporosis	0.000159	0.00114	CcSEcCtD
Nabilone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000159	0.00114	CcSEcCtD
Nabilone—Diarrhoea—Raloxifene—osteoporosis	0.000159	0.00114	CcSEcCtD
Nabilone—Dyspepsia—Pamidronate—osteoporosis	0.000158	0.00113	CcSEcCtD
Nabilone—Dizziness—Estropipate—osteoporosis	0.000158	0.00113	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—LRP5—osteoporosis	0.000157	0.00383	CbGpPWpGaD
Nabilone—Infection—Conjugated Estrogens—osteoporosis	0.000157	0.00112	CcSEcCtD
Nabilone—Diarrhoea—Ibandronate—osteoporosis	0.000157	0.00112	CcSEcCtD
Nabilone—Anorexia—Zoledronate—osteoporosis	0.000157	0.00112	CcSEcCtD
Nabilone—Decreased appetite—Pamidronate—osteoporosis	0.000156	0.00112	CcSEcCtD
Nabilone—Dizziness—Alendronate—osteoporosis	0.000156	0.00112	CcSEcCtD
Nabilone—Shock—Conjugated Estrogens—osteoporosis	0.000156	0.00111	CcSEcCtD
Nabilone—Fatigue—Pamidronate—osteoporosis	0.000155	0.00111	CcSEcCtD
Nabilone—Gastrointestinal pain—Risedronate—osteoporosis	0.000155	0.00111	CcSEcCtD
Nabilone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000154	0.00111	CcSEcCtD
Nabilone—Pain—Pamidronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Nabilone—Constipation—Pamidronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Nabilone—Diarrhoea—Calcitriol—osteoporosis	0.000154	0.0011	CcSEcCtD
Nabilone—Hypotension—Zoledronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Nabilone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000153	0.0011	CcSEcCtD
Nabilone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000153	0.0011	CcSEcCtD
Nabilone—Dizziness—Raloxifene—osteoporosis	0.000153	0.0011	CcSEcCtD
Nabilone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000153	0.00109	CcSEcCtD
Nabilone—Tension—Estradiol—osteoporosis	0.000152	0.00109	CcSEcCtD
Nabilone—Vomiting—Estropipate—osteoporosis	0.000152	0.00109	CcSEcCtD
Nabilone—Dizziness—Ibandronate—osteoporosis	0.000152	0.00109	CcSEcCtD
Nabilone—Rash—Estropipate—osteoporosis	0.000151	0.00108	CcSEcCtD
Nabilone—Dermatitis—Estropipate—osteoporosis	0.000151	0.00108	CcSEcCtD
Nabilone—Anorexia—Conjugated Estrogens—osteoporosis	0.000151	0.00108	CcSEcCtD
Nabilone—Nervousness—Estradiol—osteoporosis	0.000151	0.00108	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—LRP6—osteoporosis	0.00015	0.00366	CbGpPWpGaD
Nabilone—Back pain—Estradiol—osteoporosis	0.00015	0.00107	CcSEcCtD
Nabilone—Headache—Estropipate—osteoporosis	0.00015	0.00107	CcSEcCtD
Nabilone—Vomiting—Alendronate—osteoporosis	0.00015	0.00107	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00015	0.00107	CcSEcCtD
Nabilone—Body temperature increased—Risedronate—osteoporosis	0.00015	0.00107	CcSEcCtD
Nabilone—Abdominal pain—Risedronate—osteoporosis	0.00015	0.00107	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PTHLH—osteoporosis	0.000149	0.00364	CbGpPWpGaD
Nabilone—Rash—Alendronate—osteoporosis	0.000149	0.00106	CcSEcCtD
Nabilone—Insomnia—Zoledronate—osteoporosis	0.000149	0.00106	CcSEcCtD
Nabilone—Dermatitis—Alendronate—osteoporosis	0.000149	0.00106	CcSEcCtD
Nabilone—Feeling abnormal—Pamidronate—osteoporosis	0.000148	0.00106	CcSEcCtD
Nabilone—Hypotension—Conjugated Estrogens—osteoporosis	0.000148	0.00106	CcSEcCtD
Nabilone—Headache—Alendronate—osteoporosis	0.000148	0.00106	CcSEcCtD
Nabilone—Paraesthesia—Zoledronate—osteoporosis	0.000148	0.00106	CcSEcCtD
Nabilone—Vomiting—Raloxifene—osteoporosis	0.000148	0.00106	CcSEcCtD
Nabilone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000147	0.00105	CcSEcCtD
Nabilone—Dyspnoea—Zoledronate—osteoporosis	0.000147	0.00105	CcSEcCtD
Nabilone—Rash—Raloxifene—osteoporosis	0.000146	0.00105	CcSEcCtD
Nabilone—Dermatitis—Raloxifene—osteoporosis	0.000146	0.00105	CcSEcCtD
Nabilone—Somnolence—Zoledronate—osteoporosis	0.000146	0.00105	CcSEcCtD
Nabilone—Vomiting—Ibandronate—osteoporosis	0.000146	0.00104	CcSEcCtD
Nabilone—Tremor—Estradiol—osteoporosis	0.000145	0.00104	CcSEcCtD
Nabilone—Headache—Raloxifene—osteoporosis	0.000145	0.00104	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CALCA—osteoporosis	0.000145	0.00353	CbGpPWpGaD
Nabilone—Rash—Ibandronate—osteoporosis	0.000145	0.00104	CcSEcCtD
Nabilone—Dermatitis—Ibandronate—osteoporosis	0.000145	0.00104	CcSEcCtD
Nabilone—Dyspepsia—Zoledronate—osteoporosis	0.000145	0.00104	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000144	0.00103	CcSEcCtD
Nabilone—Ill-defined disorder—Estradiol—osteoporosis	0.000144	0.00103	CcSEcCtD
Nabilone—Headache—Ibandronate—osteoporosis	0.000144	0.00103	CcSEcCtD
Nabilone—Insomnia—Conjugated Estrogens—osteoporosis	0.000143	0.00102	CcSEcCtD
Nabilone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000143	0.00102	CcSEcCtD
Nabilone—Vomiting—Calcitriol—osteoporosis	0.000143	0.00102	CcSEcCtD
Nabilone—Decreased appetite—Zoledronate—osteoporosis	0.000143	0.00102	CcSEcCtD
Nabilone—Agitation—Estradiol—osteoporosis	0.000143	0.00102	CcSEcCtD
Nabilone—Nausea—Estropipate—osteoporosis	0.000142	0.00102	CcSEcCtD
Nabilone—Body temperature increased—Pamidronate—osteoporosis	0.000142	0.00102	CcSEcCtD
Nabilone—Abdominal pain—Pamidronate—osteoporosis	0.000142	0.00102	CcSEcCtD
Nabilone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000142	0.00102	CcSEcCtD
Nabilone—Rash—Calcitriol—osteoporosis	0.000142	0.00101	CcSEcCtD
Nabilone—Fatigue—Zoledronate—osteoporosis	0.000142	0.00101	CcSEcCtD
Nabilone—Dermatitis—Calcitriol—osteoporosis	0.000142	0.00101	CcSEcCtD
Nabilone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000141	0.00101	CcSEcCtD
Nabilone—Headache—Calcitriol—osteoporosis	0.000141	0.00101	CcSEcCtD
Nabilone—Somnolence—Conjugated Estrogens—osteoporosis	0.000141	0.00101	CcSEcCtD
Nabilone—Pain—Zoledronate—osteoporosis	0.000141	0.00101	CcSEcCtD
Nabilone—Constipation—Zoledronate—osteoporosis	0.000141	0.00101	CcSEcCtD
Nabilone—Nausea—Alendronate—osteoporosis	0.00014	0.001	CcSEcCtD
Nabilone—Malaise—Estradiol—osteoporosis	0.00014	0.001	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—P4HB—osteoporosis	0.00014	0.0034	CbGpPWpGaD
Nabilone—Hypersensitivity—Risedronate—osteoporosis	0.000139	0.000998	CcSEcCtD
Nabilone—Vertigo—Estradiol—osteoporosis	0.000139	0.000998	CcSEcCtD
Nabilone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000139	0.000997	CcSEcCtD
Nabilone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000139	0.000996	CcSEcCtD
Nabilone—Syncope—Estradiol—osteoporosis	0.000139	0.000996	CcSEcCtD
Nabilone—Nausea—Raloxifene—osteoporosis	0.000138	0.000986	CcSEcCtD
Nabilone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000138	0.000984	CcSEcCtD
Nabilone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000137	0.000983	CcSEcCtD
Nabilone—Palpitations—Estradiol—osteoporosis	0.000137	0.000981	CcSEcCtD
Nabilone—Fatigue—Conjugated Estrogens—osteoporosis	0.000136	0.000976	CcSEcCtD
Nabilone—Nausea—Ibandronate—osteoporosis	0.000136	0.000976	CcSEcCtD
Nabilone—Loss of consciousness—Estradiol—osteoporosis	0.000136	0.000976	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTH—osteoporosis	0.000136	0.00331	CbGpPWpGaD
Nabilone—Asthenia—Risedronate—osteoporosis	0.000136	0.000972	CcSEcCtD
Nabilone—Feeling abnormal—Zoledronate—osteoporosis	0.000135	0.000969	CcSEcCtD
Nabilone—Cough—Estradiol—osteoporosis	0.000135	0.000969	CcSEcCtD
Nabilone—Pain—Conjugated Estrogens—osteoporosis	0.000135	0.000968	CcSEcCtD
Nabilone—Constipation—Conjugated Estrogens—osteoporosis	0.000135	0.000968	CcSEcCtD
Nabilone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000134	0.000962	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—POMC—osteoporosis	0.000134	0.00327	CbGpPWpGaD
Nabilone—Hypertension—Estradiol—osteoporosis	0.000134	0.000959	CcSEcCtD
Nabilone—Pruritus—Risedronate—osteoporosis	0.000134	0.000958	CcSEcCtD
Nabilone—Nausea—Calcitriol—osteoporosis	0.000134	0.000955	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—RAP1A—osteoporosis	0.000133	0.00325	CbGpPWpGaD
Nabilone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000133	0.00095	CcSEcCtD
Nabilone—Hypersensitivity—Pamidronate—osteoporosis	0.000133	0.000948	CcSEcCtD
Nabilone—Myalgia—Estradiol—osteoporosis	0.000132	0.000945	CcSEcCtD
Nabilone—Arthralgia—Estradiol—osteoporosis	0.000132	0.000945	CcSEcCtD
Nabilone—Chest pain—Estradiol—osteoporosis	0.000132	0.000945	CcSEcCtD
Nabilone—Anxiety—Estradiol—osteoporosis	0.000132	0.000942	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CALCA—osteoporosis	0.000132	0.0032	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADCY5—osteoporosis	0.000131	0.0032	CbGpPWpGaD
Nabilone—Discomfort—Estradiol—osteoporosis	0.000131	0.000934	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NFATC1—osteoporosis	0.00013	0.00317	CbGpPWpGaD
Nabilone—Abdominal pain—Zoledronate—osteoporosis	0.00013	0.00093	CcSEcCtD
Nabilone—Body temperature increased—Zoledronate—osteoporosis	0.00013	0.00093	CcSEcCtD
Nabilone—Diarrhoea—Risedronate—osteoporosis	0.00013	0.000927	CcSEcCtD
Nabilone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000129	0.000926	CcSEcCtD
Nabilone—Dry mouth—Estradiol—osteoporosis	0.000129	0.000924	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—DKK1—osteoporosis	0.000129	0.00314	CbGpPWpGaD
Nabilone—Asthenia—Pamidronate—osteoporosis	0.000129	0.000924	CcSEcCtD
Nabilone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000128	0.000918	CcSEcCtD
Nabilone—Confusional state—Estradiol—osteoporosis	0.000128	0.000914	CcSEcCtD
Nabilone—Pruritus—Pamidronate—osteoporosis	0.000127	0.000911	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TLN1—osteoporosis	0.000127	0.00309	CbGpPWpGaD
Nabilone—Infection—Estradiol—osteoporosis	0.000126	0.0009	CcSEcCtD
Nabilone—Dizziness—Risedronate—osteoporosis	0.000125	0.000895	CcSEcCtD
Nabilone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000125	0.000895	CcSEcCtD
Nabilone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000125	0.000895	CcSEcCtD
Nabilone—Shock—Estradiol—osteoporosis	0.000125	0.000892	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—WNT1—osteoporosis	0.000124	0.00303	CbGpPWpGaD
Nabilone—Tachycardia—Estradiol—osteoporosis	0.000124	0.000884	CcSEcCtD
Nabilone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000123	0.000883	CcSEcCtD
Nabilone—Diarrhoea—Pamidronate—osteoporosis	0.000123	0.000881	CcSEcCtD
Nabilone—Hyperhidrosis—Estradiol—osteoporosis	0.000122	0.000876	CcSEcCtD
Nabilone—Rash—Ethinyl Estradiol—osteoporosis	0.000122	0.000876	CcSEcCtD
Nabilone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000122	0.000875	CcSEcCtD
Nabilone—Headache—Ethinyl Estradiol—osteoporosis	0.000122	0.00087	CcSEcCtD
Nabilone—Hypersensitivity—Zoledronate—osteoporosis	0.000121	0.000866	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGA—osteoporosis	0.000121	0.00295	CbGpPWpGaD
Nabilone—Vomiting—Risedronate—osteoporosis	0.00012	0.000861	CcSEcCtD
Nabilone—Rash—Risedronate—osteoporosis	0.000119	0.000854	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—ADCY5—osteoporosis	0.000119	0.0029	CbGpPWpGaD
Nabilone—Dermatitis—Risedronate—osteoporosis	0.000119	0.000853	CcSEcCtD
Nabilone—Dizziness—Pamidronate—osteoporosis	0.000119	0.000851	CcSEcCtD
Nabilone—Headache—Risedronate—osteoporosis	0.000119	0.000848	CcSEcCtD
Nabilone—Asthenia—Zoledronate—osteoporosis	0.000118	0.000844	CcSEcCtD
Nabilone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000117	0.000834	CcSEcCtD
Nabilone—Pruritus—Zoledronate—osteoporosis	0.000116	0.000832	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000115	0.000826	CcSEcCtD
Nabilone—Nausea—Ethinyl Estradiol—osteoporosis	0.000115	0.000825	CcSEcCtD
Nabilone—Insomnia—Estradiol—osteoporosis	0.000115	0.00082	CcSEcCtD
Nabilone—Vomiting—Pamidronate—osteoporosis	0.000114	0.000818	CcSEcCtD
Nabilone—Paraesthesia—Estradiol—osteoporosis	0.000114	0.000814	CcSEcCtD
Nabilone—Asthenia—Conjugated Estrogens—osteoporosis	0.000114	0.000812	CcSEcCtD
Nabilone—Rash—Pamidronate—osteoporosis	0.000113	0.000812	CcSEcCtD
Nabilone—Dermatitis—Pamidronate—osteoporosis	0.000113	0.000811	CcSEcCtD
Nabilone—Dyspnoea—Estradiol—osteoporosis	0.000113	0.000808	CcSEcCtD
Nabilone—Headache—Pamidronate—osteoporosis	0.000113	0.000806	CcSEcCtD
Nabilone—Somnolence—Estradiol—osteoporosis	0.000113	0.000806	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTHLH—osteoporosis	0.000113	0.00274	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BMP2—osteoporosis	0.000113	0.00274	CbGpPWpGaD
Nabilone—Diarrhoea—Zoledronate—osteoporosis	0.000112	0.000805	CcSEcCtD
Nabilone—Nausea—Risedronate—osteoporosis	0.000112	0.000804	CcSEcCtD
Nabilone—Pruritus—Conjugated Estrogens—osteoporosis	0.000112	0.000801	CcSEcCtD
Nabilone—Dyspepsia—Estradiol—osteoporosis	0.000111	0.000798	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGB—osteoporosis	0.00011	0.00268	CbGpPWpGaD
Nabilone—Decreased appetite—Estradiol—osteoporosis	0.00011	0.000788	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—P4HB—osteoporosis	0.00011	0.00267	CbGpPWpGaD
Nabilone—Fatigue—Estradiol—osteoporosis	0.000109	0.000781	CcSEcCtD
Nabilone—Dizziness—Zoledronate—osteoporosis	0.000109	0.000778	CcSEcCtD
Nabilone—Pain—Estradiol—osteoporosis	0.000108	0.000775	CcSEcCtD
Nabilone—Constipation—Estradiol—osteoporosis	0.000108	0.000775	CcSEcCtD
Nabilone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000108	0.000775	CcSEcCtD
Nabilone—Nausea—Pamidronate—osteoporosis	0.000107	0.000765	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTH—osteoporosis	0.000107	0.00259	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PSMA5—osteoporosis	0.000106	0.00259	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PSMA2—osteoporosis	0.000106	0.00259	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAP1A—osteoporosis	0.000105	0.00255	CbGpPWpGaD
Nabilone—Dizziness—Conjugated Estrogens—osteoporosis	0.000105	0.000749	CcSEcCtD
Nabilone—Vomiting—Zoledronate—osteoporosis	0.000105	0.000748	CcSEcCtD
Nabilone—Feeling abnormal—Estradiol—osteoporosis	0.000104	0.000747	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CNR2—osteoporosis	0.000104	0.00253	CbGpPWpGaD
Nabilone—Rash—Zoledronate—osteoporosis	0.000104	0.000741	CcSEcCtD
Nabilone—Gastrointestinal pain—Estradiol—osteoporosis	0.000104	0.000741	CcSEcCtD
Nabilone—Dermatitis—Zoledronate—osteoporosis	0.000104	0.000741	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000103	0.00251	CbGpPWpGaD
Nabilone—Headache—Zoledronate—osteoporosis	0.000103	0.000737	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NFATC1—osteoporosis	0.000102	0.00249	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DKK1—osteoporosis	0.000101	0.00247	CbGpPWpGaD
Nabilone—Vomiting—Conjugated Estrogens—osteoporosis	0.000101	0.00072	CcSEcCtD
Nabilone—Body temperature increased—Estradiol—osteoporosis	0.0001	0.000716	CcSEcCtD
Nabilone—Abdominal pain—Estradiol—osteoporosis	0.0001	0.000716	CcSEcCtD
Nabilone—Rash—Conjugated Estrogens—osteoporosis	9.98e-05	0.000714	CcSEcCtD
Nabilone—Dermatitis—Conjugated Estrogens—osteoporosis	9.97e-05	0.000713	CcSEcCtD
Nabilone—Headache—Conjugated Estrogens—osteoporosis	9.91e-05	0.000709	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CALCA—osteoporosis	9.91e-05	0.00241	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—WNT1—osteoporosis	9.77e-05	0.00238	CbGpPWpGaD
Nabilone—Nausea—Zoledronate—osteoporosis	9.76e-05	0.000698	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—POMC—osteoporosis	9.66e-05	0.00235	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGA—osteoporosis	9.5e-05	0.00231	CbGpPWpGaD
Nabilone—Nausea—Conjugated Estrogens—osteoporosis	9.4e-05	0.000673	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ADCY5—osteoporosis	9.36e-05	0.00228	CbGpPWpGaD
Nabilone—Hypersensitivity—Estradiol—osteoporosis	9.33e-05	0.000668	CcSEcCtD
Nabilone—Asthenia—Estradiol—osteoporosis	9.09e-05	0.00065	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—KL—osteoporosis	9e-05	0.00219	CbGpPWpGaD
Nabilone—Pruritus—Estradiol—osteoporosis	8.96e-05	0.000641	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTHLH—osteoporosis	8.83e-05	0.00215	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BMP2—osteoporosis	8.83e-05	0.00215	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—POMC—osteoporosis	8.78e-05	0.00214	CbGpPWpGaD
Nabilone—Diarrhoea—Estradiol—osteoporosis	8.67e-05	0.00062	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGB—osteoporosis	8.64e-05	0.0021	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6R—osteoporosis	8.56e-05	0.00208	CbGpPWpGaD
Nabilone—Dizziness—Estradiol—osteoporosis	8.38e-05	0.000599	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PSMA2—osteoporosis	8.34e-05	0.00203	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PSMA5—osteoporosis	8.34e-05	0.00203	CbGpPWpGaD
Nabilone—Vomiting—Estradiol—osteoporosis	8.05e-05	0.000576	CcSEcCtD
Nabilone—Rash—Estradiol—osteoporosis	7.99e-05	0.000571	CcSEcCtD
Nabilone—Dermatitis—Estradiol—osteoporosis	7.98e-05	0.000571	CcSEcCtD
Nabilone—Headache—Estradiol—osteoporosis	7.94e-05	0.000568	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CALCA—osteoporosis	7.77e-05	0.00189	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—POMC—osteoporosis	7.58e-05	0.00185	CbGpPWpGaD
Nabilone—Nausea—Estradiol—osteoporosis	7.52e-05	0.000538	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—KL—osteoporosis	7.06e-05	0.00172	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADCY5—osteoporosis	7.05e-05	0.00172	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—POMC—osteoporosis	6.89e-05	0.00168	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—osteoporosis	6.82e-05	0.00166	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6R—osteoporosis	6.72e-05	0.00164	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS2—osteoporosis	6.17e-05	0.0015	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LEP—osteoporosis	6.03e-05	0.00147	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ESR1—osteoporosis	5.76e-05	0.0014	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADCY5—osteoporosis	5.53e-05	0.00135	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS1—osteoporosis	5.38e-05	0.00131	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—osteoporosis	5.35e-05	0.0013	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—POMC—osteoporosis	5.18e-05	0.00126	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6R—osteoporosis	5.06e-05	0.00123	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—osteoporosis	4.99e-05	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS2—osteoporosis	4.84e-05	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—osteoporosis	4.74e-05	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ESR1—osteoporosis	4.52e-05	0.0011	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS1—osteoporosis	4.22e-05	0.00103	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—POMC—osteoporosis	4.07e-05	0.00099	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6R—osteoporosis	3.97e-05	0.000966	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—osteoporosis	3.91e-05	0.000952	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—osteoporosis	3.81e-05	0.000928	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—osteoporosis	3e-05	0.000729	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—osteoporosis	2.99e-05	0.000728	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—osteoporosis	2.99e-05	0.000728	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—osteoporosis	2.35e-05	0.000572	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—osteoporosis	2.35e-05	0.000571	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—osteoporosis	2.25e-05	0.000548	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—osteoporosis	1.77e-05	0.00043	CbGpPWpGaD
